Opthea Ltd (CKDXF) SEC Filings & Financial Intelligence
Opthea Ltd (CKDXF) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CKDXF
CIK: 1815620
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 06/30
State: C3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte Touche Tohmatsu
Auditor SinceSince 6/30/2020 12:00:00 AM
Lead Engagement PartnerChetan Vaghela
Audit LocationMelbourne, Australia
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-07-07 | — | SCHEDULE 13G/A Filing | 0001214659-26-008258 | View SEC Doc Filr Page |
| 15F-12B | 2025-11-20 | — | 15F-12B | 0001193125-25-289744 | View SEC Doc Filr Page |
| 6-K | 2025-11-20 | 2025-11-20 | 6-K | 0001193125-25-289730 | View SEC Doc Filr Page |
| 6-K | 2025-11-12 | 2025-11-12 | 6-K | 0001193125-25-276112 | View SEC Doc Filr Page |
| S-8 POS | 2025-11-10 | — | S-8 POS | 0001193125-25-273380 | View SEC Doc Filr Page |
| 25 | 2025-11-10 | — | 25 | 0001193125-25-273377 | View SEC Doc Filr Page |
| 6-K | 2025-10-31 | 2025-10-31 | 6-K | 0001193125-25-259864 | View SEC Doc Filr Page |
| 6-K | 2025-10-30 | 2025-10-30 | 6-K | 0001193125-25-257488 | View SEC Doc Filr Page |
| 6-K | 2025-10-27 | 2025-10-27 | 6-K | 0001193125-25-250608 | View SEC Doc Filr Page |
| 6-K | 2025-10-10 | 2025-10-10 | 6-K | 0001193125-25-236292 | View SEC Doc Filr Page |
| 6-K | 2025-10-06 | 2025-10-06 | 6-K | 0001193125-25-230839 | View SEC Doc Filr Page |
| 20-F | 2025-09-15 | 2025-06-30 | 20-F | 0001193125-25-202743 | View SEC Doc Filr Page |
| 6-K | 2025-09-15 | 2025-09-15 | 6-K | 0001193125-25-202677 | View SEC Doc Filr Page |
| 6-K | 2025-08-29 | 2025-08-29 | 6-K | 0001193125-25-191693 | View SEC Doc Filr Page |
| 6-K | 2025-08-20 | 2025-08-20 | 6-K | 0000950170-25-110268 | View SEC Doc Filr Page |
| 6-K | 2025-08-19 | 2025-08-19 | 6-K | 0000950170-25-109928 | View SEC Doc Filr Page |
| 6-K | 2025-08-19 | 2025-08-18 | 6-K | 0000950170-25-109921 | View SEC Doc Filr Page |
| 6-K | 2025-06-02 | 2025-06-02 | 6-K | 0000950170-25-080006 | View SEC Doc Filr Page |
| 6-K | 2025-04-10 | 2025-04-10 | 6-K | 0000950170-25-052661 | View SEC Doc Filr Page |
| 6-K | 2025-03-31 | 2025-03-31 | 6-K | 0000950170-25-047169 | View SEC Doc Filr Page |
| 6-K | 2025-03-24 | 2025-03-24 | 6-K | 0000950170-25-043476 | View SEC Doc Filr Page |
| 6-K | 2025-03-03 | 2025-03-03 | 6-K | 0000950170-25-030353 | View SEC Doc Filr Page |
| 6-K | 2025-02-28 | 2025-02-28 | 6-K | 0000950170-25-029489 | View SEC Doc Filr Page |
| 6-K | 2025-02-26 | 2025-02-26 | 6-K | 0000950170-25-027304 | View SEC Doc Filr Page |
| 6-K | 2025-02-18 | 2025-02-18 | 6-K | 0000950170-25-021780 | View SEC Doc Filr Page |